Gabapentin Tablet, Film Coated
Product Images NDC 71335-2765

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Creatinine Clearance (Gabapentin Fig1)

This text provides a formula for calculating creatinine clearance (Lt) based on age, weight, and gender-specific adjustment for females. The formula involves multiplying age in years by weight in kilograms and then a gender-specific coefficient. It also mentions the coefficient value (0.85) for female patients. This formula can be used in clinical settings to estimate renal function.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig2)

The text provides a graph showing the weekly mean pain scores observed for different treatments in the ITT population in Study 1. The treatments compared are placebo and Gabapentin at a dose of 300 mg/day. The graph shows the changes in pain scores over time for each treatment group.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig3)

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

Not available.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

FDA Label Image

Chemical Structure (Gabapentin Str)

FDA Label Image

Label (Lbl713352765)

This is a description of Gabapentin tablets, USP, containing 800 mg of Gabapentin per film-coated tablet. The tablets are to be stored at a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The tablets should be kept out of reach of children and dispensed in tight, child-resistant containers. The NDC number for these tablets is 71335-2765-1. It is recommended to scan the package insert QR code for complete prescribing information. The tablets are to be repackaged by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.